Constella

Constella is a prescription medication that contains linaclotide as its active ingredient. It is used for the treatment of moderate to severe irritable bowel syndrome with constipation (IBS-C) in adults. Constella belongs to a class of medicines called guanylate cyclase-C (GC-C) agonists. It works locally in the intestines by increasing fluid secretion and accelerating bowel movements, which helps relieve constipation and reduce abdominal pain. Constella is available only with a valid prescription and should be used under medical supervision.

What Is Constella Used For?

• Constella is approved for the treatment of moderate to severe irritable bowel syndrome with constipation (IBS-C) in adults.
• In Canada and some other countries, linaclotide (as Constella) is approved for the treatment of chronic idiopathic constipation (CIC) in adults, in addition to IBS‑C. EMA approvals are limited to IBS-C in adults.

Below are the important risks and safety warnings that patients should understand before starting their treatment with Constella capsules.

• Severe Diarrhea: The most common adverse reaction is diarrhea, which may occasionally be severe. Treatment should be discontinued, and medical advice should be sought if severe diarrhea occurs.
• Dehydration Risk: Patients, particularly the elderly, should maintain adequate fluid intake. Caution is advised for those people who are at higher risk of dehydration.
• Gastrointestinal Obstruction: Constella must not be used in people with known or suspected mechanical gastrointestinal obstruction.

Who Should Not Take Constella?

Constella should not be used in patients with:

• Hypersensitivity to linaclotide or any excipients
• Known or suspected mechanical gastrointestinal obstruction

Before starting Constella, a healthcare provider should:

• Confirm the diagnosis of IBS-C
• Exclude organic causes of constipation
• Assess risk factors for dehydration
• Advise patients to maintain adequate fluid intake

This is not a complete list of Constella side effects. If you notice other adverse reactions, report them to your doctor immediately.

Constella contains linaclotide, a guanylate cyclase-C (GC-C) receptor agonist that works locally in the intestine. After oral administration, linaclotide binds to GC-C receptors on the luminal surface of the intestinal epithelium. This activation increases intracellular and extracellular levels of cyclic guanosine monophosphate (cGMP). The rise in cGMP leads to:

• Increased intestinal fluid secretion through activation of the CFTR ion channel, promoting chloride and bicarbonate secretion into the intestinal lumen
• Accelerated intestinal transit helps relieve constipation
• Reduction in visceral pain signaling, as extracellular cGMP is believed to decrease the activity of pain-sensing nerves in the intestine

Linaclotide acts locally within the gastrointestinal tract and has minimal systemic absorption.

• Route: Swallow whole with water. Do not crush or chew the capsules.
• Timing: Take once a day on an empty stomach, at least 30 minutes before the first meal of your day.
• Consistency: Take at the same time each day to maintain effectiveness.
• Supervision: Use only under medical supervision, with monitoring for diarrhea and dehydration risk.
• Missed Dose: If a Constella dose is missed, skip it and take the next dose at the usual time. Do not double up.

Constella overdose experience is limited. There is no specific antidote for Constella (linaclotide) overdose; treatment is supportive and symptomatic.

• Potential symptoms of taking too much Constella may include:
  • Diarrhea (most common)
  • Abdominal pain
  • Flatulence
  • Headache

If a Constella overdose is suspected, immediate medical attention is required. Patients should contact their provider or seek emergency care promptly.

Constella (linaclotide) dosing should be individualized and monitored by a healthcare provider.

Constella and Linzess contain the same active ingredient, linaclotide. They are marketed under different brand names in different countries. Although the active ingredient and mechanism of action are the same, approved indications and available strengths may vary by country.

No clinically significant drug interactions have been identified because Constella (linaclotide is minimally absorbed from the gastrointestinal tract and acts locally within the intestine. The primary clinical concern is severe diarrhea, which can reduce the efficacy of other oral medications. Physicians should monitor patients and adjust therapy if absorption issues are suspected.

If Constella (linaclotide) is not effective or is not available in your region, several alternative medications are available. Your provider will choose the most appropriate option based on your symptoms, medical history, and response to previous treatments.

• Linzess (linaclotide)
• Trulance (plecanatide)
• Amitiza (lubiprostone)
• Motegrity (prucalopride)
• Ibsrela (tenapanor)
• Lactulose

Many patients in the U.S. choose to buy Constella from Canada because prescription medications are often significantly more affordable than U.S. retail pharmacy prices. For individuals managing treatment, ordering through a licensed Canadian pharmacy can provide meaningful cost savings without compromising quality or safety.

At Polar Bear Meds, patients can buy Constella online through a trusted network of licensed Canadian and international pharmacies that follow strict regulatory and dispensing standards. Every order requires a valid prescription from a licensed doctor or healthcare provider to ensure safe and appropriate use.

When you order Constella from Canada through Polar Bear Meds, you may benefit from:

• Savings of up to 80–90% compared to U.S. retail prices
• 10% off your first order with Constella coupon code “WELCOMEPB10”
• Competitive everyday pricing
• Referral savings programs
• Friendly, responsive customer support
• Typical delivery in 3–5 business days via Xpress Post
• Secure ordering and convenient online order tracking

• https://www.ema.europa.eu/en/documents/assessment-report/constella-epar-public-assessment-report_en.pdf
• http://medicines.org.uk/emc/product/2041/smpc#gref
• https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00177
• https://www.drugs.com/uk/constella.html